Axon Clinical s.r.o.

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Crohn's disease2 trials
• Diabetic eye disease2 trials
• Ulcerative colitis2 trials
• Macular degeneration1 trial

Phase

• Phase 34 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed3 trials
• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Bayer2 trials
• Janssen Research & Development, LLC2 trials
• EyePoint Pharmaceuticals, Inc.1 trial
• Takeda1 trial

Running trials

• Active, not recruiting

  CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

  NCT07449923· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Recruiting

  A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  NCT07196722· Phase 2/3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

  NCT04722991· Phase 2· Bayer· Source

• Completed

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· Phase 3· Bayer· Source

• Completed

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· Phase 3· Takeda· Source